ScandiDos AB (SDOS) - Total Liabilities

Latest as of April 2026: Skr24.31 Million SEK ≈ $2.62 Million USD

Based on the latest financial reports, ScandiDos AB (SDOS) has total liabilities worth Skr24.31 Million SEK (≈ $2.62 Million USD) as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore SDOS net assets growth trend to track the company's year-over-year net asset growth rate.

ScandiDos AB - Total Liabilities Trend (2011–2026)

This chart illustrates how ScandiDos AB's total liabilities have evolved over time, based on quarterly financial data. See ScandiDos AB free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

ScandiDos AB Competitors by Total Liabilities

The table below lists competitors of ScandiDos AB ranked by their total liabilities.

Company Country Total Liabilities
BACTECH ENVIRONMENT.CORP.
F:0BT1
Germany €4.90 Million
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN
USA $10.33 Million
Archies Limited
NSE:ARCHIES
India Rs602.64 Million
Foresight Autonomous Holdings Ltd ADR
NASDAQ:FRSX
USA $2.92 Million
Nala Digital Commerce Ltd
TA:SEFA
Israel ILA10.28 Million
Ahlada Engineers Limited
NSE:AHLADA
India Rs785.46 Million
KNM Group Bhd
KLSE:7164
Malaysia RM2.55 Billion
Megapower Makmur TBK PT
JK:MPOW
Indonesia Rp38.61 Billion

Liability Composition Analysis (2011–2026)

This chart breaks down ScandiDos AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of ScandiDos AB.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.58 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.37 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ScandiDos AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ScandiDos AB (2011–2026)

The table below shows the annual total liabilities of ScandiDos AB from 2011 to 2026.

Year Total Liabilities Change
2026-04-30 Skr24.31 Million
≈ $2.62 Million
-14.39%
2025-04-30 Skr28.40 Million
≈ $3.06 Million
-23.63%
2024-04-30 Skr37.19 Million
≈ $4.00 Million
+20.86%
2023-04-30 Skr30.77 Million
≈ $3.31 Million
+6.14%
2022-04-30 Skr28.99 Million
≈ $3.12 Million
-9.36%
2021-04-30 Skr31.98 Million
≈ $3.44 Million
+29.27%
2020-04-30 Skr24.74 Million
≈ $2.66 Million
-39.02%
2019-04-30 Skr40.57 Million
≈ $4.37 Million
+107.55%
2018-04-30 Skr19.55 Million
≈ $2.10 Million
+0.33%
2017-04-30 Skr19.48 Million
≈ $2.10 Million
-23.57%
2016-04-30 Skr25.49 Million
≈ $2.74 Million
+40.94%
2015-04-30 Skr18.09 Million
≈ $1.95 Million
+35.93%
2014-04-30 Skr13.30 Million
≈ $1.43 Million
-30.67%
2013-04-30 Skr19.19 Million
≈ $2.07 Million
+58.75%
2012-04-30 Skr12.09 Million
≈ $1.30 Million
+62.99%
2011-04-30 Skr7.42 Million
≈ $798.19K
--

About ScandiDos AB

ST:SDOS Sweden Medical Devices
Market Cap
$5.09 Million
Skr47.32 Million SEK
Market Cap Rank
#28513 Global
#641 in Sweden
Share Price
Skr0.83
Change (1 day)
+0.00%
52-Week Range
Skr0.80 - Skr1.37
All Time High
Skr11.20
About

ScandiDos AB (publ), together with its subsidiaries, provides measurement phantoms and software solutions for the quality assurance and validation of dynamic and modulated treatments adopted in clinics in the United States, Europe, Asia, and internationally. The company offers Delta4 products comprising Delta4 Phantom+, Delta4Phantom+MR, Delta4 HexaMotion, Delta4Insight, Delta4DVH Anatomy, Delta4… Read more